Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fibroins | 6 | 2020 | 55 | 0.880 |
Why?
|
Muscle, Smooth | 9 | 2022 | 933 | 0.830 |
Why?
|
Caveolae | 3 | 2012 | 57 | 0.820 |
Why?
|
Urinary Bladder | 10 | 2018 | 1171 | 0.770 |
Why?
|
Urinary Bladder, Overactive | 5 | 2017 | 106 | 0.720 |
Why?
|
Muscle Contraction | 9 | 2022 | 1241 | 0.660 |
Why?
|
Neuropilin-2 | 3 | 2022 | 54 | 0.470 |
Why?
|
Esophagoplasty | 3 | 2020 | 43 | 0.460 |
Why?
|
Caveolin 1 | 3 | 2012 | 264 | 0.460 |
Why?
|
Tissue Scaffolds | 6 | 2020 | 957 | 0.460 |
Why?
|
Inosine | 3 | 2018 | 133 | 0.420 |
Why?
|
Receptors, Purinergic | 1 | 2012 | 66 | 0.420 |
Why?
|
Spinal Cord Injuries | 5 | 2018 | 930 | 0.400 |
Why?
|
Regeneration | 5 | 2020 | 1485 | 0.320 |
Why?
|
Urinary Bladder Diseases | 2 | 2018 | 166 | 0.250 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2012 | 686 | 0.230 |
Why?
|
Synaptotagmin II | 1 | 2021 | 15 | 0.210 |
Why?
|
Synaptotagmin I | 1 | 2021 | 36 | 0.200 |
Why?
|
Myenteric Plexus | 1 | 2021 | 39 | 0.200 |
Why?
|
Gastrointestinal Motility | 1 | 2022 | 225 | 0.190 |
Why?
|
Botulinum Toxins | 1 | 2021 | 192 | 0.180 |
Why?
|
Silk | 2 | 2020 | 87 | 0.170 |
Why?
|
Gastric Fundus | 2 | 2021 | 39 | 0.170 |
Why?
|
Urinary Bladder, Neurogenic | 2 | 2018 | 165 | 0.170 |
Why?
|
Stomach Diseases | 1 | 2019 | 134 | 0.160 |
Why?
|
Tissue Engineering | 3 | 2020 | 1877 | 0.150 |
Why?
|
Gastric Emptying | 1 | 2019 | 233 | 0.150 |
Why?
|
Urinary Bladder Neck Obstruction | 1 | 2017 | 80 | 0.140 |
Why?
|
Receptor, Adenosine A2A | 1 | 2017 | 124 | 0.140 |
Why?
|
Stomach | 1 | 2021 | 697 | 0.140 |
Why?
|
Rats | 10 | 2018 | 24265 | 0.140 |
Why?
|
Rats, Sprague-Dawley | 8 | 2018 | 8300 | 0.130 |
Why?
|
Disease Models, Animal | 9 | 2018 | 18006 | 0.120 |
Why?
|
Carbachol | 2 | 2022 | 226 | 0.120 |
Why?
|
Mucous Membrane | 1 | 2018 | 670 | 0.120 |
Why?
|
Colon | 1 | 2022 | 1773 | 0.120 |
Why?
|
Myosin Type V | 1 | 2014 | 34 | 0.120 |
Why?
|
Esophagus | 2 | 2017 | 1017 | 0.120 |
Why?
|
Muscle Relaxation | 1 | 2014 | 142 | 0.120 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 808 | 0.120 |
Why?
|
Esophageal Achalasia | 1 | 2014 | 91 | 0.110 |
Why?
|
Penis | 1 | 2014 | 216 | 0.110 |
Why?
|
Rats, Inbred WKY | 1 | 2012 | 158 | 0.110 |
Why?
|
Rats, Inbred SHR | 1 | 2012 | 195 | 0.110 |
Why?
|
Caveolins | 1 | 2012 | 104 | 0.110 |
Why?
|
Myosin Heavy Chains | 1 | 2014 | 414 | 0.100 |
Why?
|
Laminectomy | 1 | 2013 | 232 | 0.100 |
Why?
|
Diabetes Complications | 1 | 2019 | 1359 | 0.100 |
Why?
|
Evoked Potentials | 1 | 2018 | 1057 | 0.100 |
Why?
|
Caveolin 3 | 2 | 2012 | 25 | 0.100 |
Why?
|
Caveolin 2 | 2 | 2012 | 26 | 0.100 |
Why?
|
Signal Transduction | 2 | 2012 | 23387 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 264 | 0.100 |
Why?
|
Spinal Cord Compression | 1 | 2013 | 235 | 0.100 |
Why?
|
Animals | 22 | 2022 | 168561 | 0.100 |
Why?
|
Urodynamics | 3 | 2018 | 347 | 0.090 |
Why?
|
Swine | 4 | 2020 | 5934 | 0.070 |
Why?
|
Isometric Contraction | 2 | 2018 | 147 | 0.070 |
Why?
|
beta-Cyclodextrins | 1 | 2007 | 64 | 0.070 |
Why?
|
Cholinergic Agonists | 1 | 2007 | 74 | 0.070 |
Why?
|
Potassium Chloride | 1 | 2007 | 238 | 0.070 |
Why?
|
Bradykinin | 1 | 2007 | 214 | 0.070 |
Why?
|
Phenylephrine | 1 | 2007 | 301 | 0.070 |
Why?
|
Wound Healing | 1 | 2017 | 2781 | 0.070 |
Why?
|
Nitric Oxide | 1 | 2014 | 2128 | 0.060 |
Why?
|
Angiotensin II | 1 | 2007 | 881 | 0.060 |
Why?
|
Vasoconstrictor Agents | 1 | 2007 | 643 | 0.060 |
Why?
|
Microscopy, Electron | 1 | 2007 | 2645 | 0.060 |
Why?
|
Vasodilator Agents | 1 | 2007 | 976 | 0.050 |
Why?
|
Serotonin | 1 | 2007 | 1024 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5724 | 0.050 |
Why?
|
rho-Associated Kinases | 2 | 2012 | 279 | 0.050 |
Why?
|
Models, Biological | 1 | 2017 | 9581 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4414 | 0.050 |
Why?
|
Gene Knock-In Techniques | 1 | 2021 | 418 | 0.050 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2007 | 1221 | 0.040 |
Why?
|
Receptors, Purinergic P1 | 1 | 2018 | 109 | 0.040 |
Why?
|
DNA | 1 | 2012 | 7289 | 0.040 |
Why?
|
Postprandial Period | 1 | 2019 | 292 | 0.040 |
Why?
|
Caustics | 1 | 2017 | 29 | 0.040 |
Why?
|
Receptors, Muscarinic | 1 | 2018 | 156 | 0.040 |
Why?
|
Gastroparesis | 1 | 2019 | 131 | 0.040 |
Why?
|
Adenosine A2 Receptor Antagonists | 1 | 2017 | 48 | 0.040 |
Why?
|
Mice | 6 | 2022 | 81045 | 0.040 |
Why?
|
Xanthines | 1 | 2017 | 121 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 625 | 0.030 |
Why?
|
Synaptophysin | 1 | 2015 | 141 | 0.030 |
Why?
|
Neuromuscular Junction | 1 | 2018 | 397 | 0.030 |
Why?
|
Triazines | 1 | 2017 | 316 | 0.030 |
Why?
|
Models, Animal | 1 | 2021 | 2170 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2021 | 2638 | 0.030 |
Why?
|
Male | 10 | 2018 | 349538 | 0.030 |
Why?
|
Rats, Transgenic | 1 | 2014 | 71 | 0.030 |
Why?
|
TRPV Cation Channels | 1 | 2015 | 235 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 12071 | 0.030 |
Why?
|
Potassium Channels | 1 | 2017 | 562 | 0.030 |
Why?
|
Nitric Oxide Donors | 1 | 2014 | 121 | 0.030 |
Why?
|
Neurofilament Proteins | 1 | 2015 | 318 | 0.030 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2014 | 255 | 0.030 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2014 | 170 | 0.030 |
Why?
|
Bombyx | 1 | 2013 | 55 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2022 | 14554 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8626 | 0.030 |
Why?
|
Mice, Inbred DBA | 1 | 2014 | 642 | 0.030 |
Why?
|
X-Ray Microtomography | 1 | 2015 | 428 | 0.030 |
Why?
|
Myosin Light Chains | 1 | 2012 | 121 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2013 | 962 | 0.020 |
Why?
|
Triazoles | 1 | 2017 | 907 | 0.020 |
Why?
|
Urothelium | 1 | 2013 | 277 | 0.020 |
Why?
|
Cell Shape | 1 | 2012 | 375 | 0.020 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2012 | 241 | 0.020 |
Why?
|
Sus scrofa | 1 | 2012 | 437 | 0.020 |
Why?
|
Urologic Surgical Procedures | 1 | 2013 | 301 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2019 | 1368 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2012 | 563 | 0.020 |
Why?
|
Muscles | 1 | 2014 | 1617 | 0.020 |
Why?
|
Species Specificity | 1 | 2013 | 2479 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 11695 | 0.020 |
Why?
|
Sulfonamides | 1 | 2017 | 1932 | 0.020 |
Why?
|
Organ Specificity | 1 | 2012 | 2003 | 0.020 |
Why?
|
Cytoskeleton | 1 | 2012 | 1185 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 1969 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2021 | 13029 | 0.020 |
Why?
|
Metformin | 1 | 2012 | 829 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 21821 | 0.020 |
Why?
|
Blood Glucose | 1 | 2019 | 6249 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2013 | 1731 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1675 | 0.020 |
Why?
|
Down-Regulation | 1 | 2012 | 3001 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5180 | 0.020 |
Why?
|
Gene Deletion | 1 | 2012 | 2751 | 0.020 |
Why?
|
Multiple Sclerosis | 1 | 2018 | 3076 | 0.010 |
Why?
|
Intestines | 1 | 2012 | 1923 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4211 | 0.010 |
Why?
|
Humans | 8 | 2022 | 742088 | 0.010 |
Why?
|
Female | 6 | 2018 | 379592 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2012 | 3038 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4465 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 7790 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29010 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7873 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18355 | 0.010 |
Why?
|
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_